tetraethylammonium has been researched along with Dementias, Transmissible in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Excerpt | Relevance | Reference |
---|---|---|
"3." | 1.32 | Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier. ( Dohgu, S; Higuchi, S; Katamine, S; Kataoka, Y; Naito, M; Niwa, M; Sawada, Y; Shirabe, S; Takata, F; Tsuruo, T; Yamauchi, A, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dohgu, S | 1 |
Yamauchi, A | 1 |
Takata, F | 1 |
Sawada, Y | 1 |
Higuchi, S | 1 |
Naito, M | 1 |
Tsuruo, T | 1 |
Shirabe, S | 1 |
Niwa, M | 1 |
Katamine, S | 1 |
Kataoka, Y | 1 |
1 other study available for tetraethylammonium and Dementias, Transmissible
Article | Year |
---|---|
Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cation Transp | 2004 |